What is the recommended dosing schedule for primidone in adults, including starting dose, titration, maintenance range, and maximum dose?

Primidone Dosing for Adults

For adults and children ≥8 years starting primidone, begin with 100–125 mg at bedtime for 3 days, then increase by 100–125 mg every 3 days until reaching a maintenance dose of 750 mg/day (250 mg three times daily), with a maximum of 2000 mg/day if needed. 1

Initial Titration Schedule (Treatment-Naïve Patients ≥8 Years)

The FDA-approved titration follows a structured 10-day schedule 1:

• Days 1–3: 100–125 mg at bedtime
• Days 4–6: 100–125 mg twice daily (total 200–250 mg/day)
• Days 7–9: 100–125 mg three times daily (total 300–375 mg/day)
• Day 10 onward: 250 mg three times daily (750 mg/day maintenance)

Maintenance Dosing

The standard maintenance dose is 750–1000 mg/day (250 mg three to four times daily) for most adults and children ≥8 years. 1

• If inadequate response occurs, increase to 1250–1500 mg/day (five to six 250 mg tablets daily) 1
• Maximum dose: 2000 mg/day (500 mg four times daily) 1
• Therapeutic serum levels: 5–12 mcg/mL 1

Pediatric Dosing (Children <8 Years)

For younger children, use a more conservative approach 1:

• Days 1–3: 50 mg at bedtime
• Days 4–6: 50 mg twice daily
• Days 7–9: 100 mg twice daily
• Day 10 onward: 125–250 mg three times daily (maintenance)
• Alternative weight-based dosing: 10–25 mg/kg/day in divided doses 1

Transitioning from Other Anticonvulsants

When switching from another antiepileptic drug, start primidone at 100–125 mg at bedtime while gradually tapering the existing medication over at least 2 weeks. 1

This allows cross-titration to minimize breakthrough seizures while establishing therapeutic primidone levels 1.

Strategies to Minimize Acute Intolerance

Acute neurotoxic reactions (somnolence, ataxia, dizziness, nausea) occur in up to 82% of patients after the first dose, but pre-treatment with phenobarbital 10 mg/day for 2–3 weeks reduces this to 17% through functional cross-tolerance. 2

Alternative approaches include 3, 4:

• Pre-treating with phenobarbital before initiating primidone, then stopping phenobarbital when primidone reaches 500 mg/day 3
• Starting at very low doses (25–50 mg) using suspension formulations, though this does not consistently improve tolerability compared to standard tablet initiation 4

Dose-Response Considerations

Low-dose primidone (250 mg/day) demonstrates equal or superior efficacy compared to high doses (750 mg/day) for essential tremor, with significantly fewer adverse effects and better treatment retention. 5

• In essential tremor trials, 250 mg/day was as effective as 750 mg/day over 12 months 5
• Higher doses (750 mg/day) caused more treatment discontinuations due to side effects (p<0.03) 5
• Single 250 mg doses reduced tremor amplitude by 60% within 1–7 hours, independent of phenobarbital metabolite formation 6

Monitoring Requirements

Obtain complete blood count and comprehensive metabolic panel (SMA-12) every 6 months during chronic therapy. 1

• Check serum primidone levels when optimizing dosage; therapeutic range is 5–12 mcg/mL 1
• Monitor for signs of toxicity in nursing infants if the mother is taking primidone, as the drug appears in breast milk in substantial quantities 1

Common Pitfalls

• Avoid rapid titration: The standard 3-day incremental schedule minimizes acute intolerance while achieving therapeutic levels within 10 days 1
• Do not substitute phenobarbital for primidone: Primidone itself is pharmacologically active; tremor control is lost when phenobarbital is substituted, despite adequate phenobarbital levels 6
• Consider phenobarbital pre-treatment for sensitive patients: This strategy prevents acute intolerance in patients with known sensitivity to new antiepileptic drugs 3, 2
• Start lower in essential tremor: For tremor management specifically, consider initiating at 250 mg/day rather than titrating to 750 mg/day, as lower doses are equally effective with better tolerability 5